Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Its clinical focus is on Parkinson's disease and neuropathic pain. The Company has a strong patent portfolio with several patents granted worldwide.

Newron Pharmaceuticals was established in 1999 as a spin-off from Pharmacia & Upjohn and are headquartered in Bresso, near Milan, Italy.